Navigation Links
Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research

says when most attacks occur, they happen in 3 to 4 feet of water. "But often, that can mean you're several hundred feet away from the beach," he notes. "Also, most attacks occur in water that is murky and not very clear.

"A greater percentage of beachgoers are injured by jellyfish, stingrays or hardhead and gafftop fishes, which have poisonous spines. They are more likely to cause harm than a shark."

He says when shark attacks occur, often they are accidental.

"Humans are not a shark's preferred food choice," he says.

"They don't regard the human shape as a prey item. Sometimes you hear reports of surfers having their boards hit by a shark, and it's probably because the board resembles the shape of a seal, which is a prime food source for sharks."

McEachran says some common sense can go a long way in avoiding contact with sharks.

"Sharks generally don't like to be around people," he adds.

"Most people are safe at the beach. To put your mind at ease, go to a beach that has lifeguards. They should be looking for possible sharks.

"Shark attacks are like airplane crashes," he notes. "The vast majority of airplane trips are safe, but when a crash occurs, it gets big headlines. If you use some good common sense in the water, you should be fine."


'"/>

Source:


Page: 1 2

Related biology news :

1. Agilent Technologies releases automated literature search tool for biology researchers
2. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
3. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
4. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma
5. Agilent Technologies introduces high-capacity human protein removal system for proteomics research
6. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
7. Amgen introduces comprehensive financial assistance programs for cancer patients
8. Researchers test new therapy for advanced melanoma
9. Combination therapy shows promising results in patients with advanced lung cancer
10. An advanced genetic diagnostic method for multiple myeloma
11. Molecular differences between early and advanced melanomas could provide new drug targets
Post Your Comments:
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
(Date:6/18/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... market announces that its Wocket® smart wallet will be the ... scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive one ... Inc.,s CEO Gino Pereira will be discussing its ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... scientific basis for eventual treatment, neurology researchers have shown ... protein that helps keep brain activity in balance. The ... an underlying reason for seizures and memory defects experienced ... (TBI). , "A traumatic brain injury occurs to someone ...
... an immune response against HIV, research funded by the Wellcome ... in the US has found that bigger is not necessarily ... a profound impact on the development of a vaccine against ... bigger the immune response, the more effective it will be ...
... Scientists have discovered that autoimmunity can be triggered in the ... cells fail to recognize just one of the body's thousands ... view that autoimmunity can start in this cradle of the ... diseases emerge, such as the pancreas in the case of ...
Cached Biology News:How brain injury leads to seizures, memory problems 2Quality not quantity important for immune response to HIV 2Autoimmune disease triggered if T cells miss a single protein early on 2Autoimmune disease triggered if T cells miss a single protein early on 3
(Date:7/3/2015)... 2015 Forskare kan ... på  http://www.openinnovationinscience.at till det återkommande utbildningsprogrammet ... hålls i Wien .  ... internationella forskare och vetenskapsmän som genomfördes av ... största utmaningar bristen på incitament för att ...
(Date:7/3/2015)... , July 3, 2015  Pomerantz LLP announces that ... Biotechnology, Inc. ("Puma" or the "Company")(NYSE: PBYI ) ... in United States District Court, Central District of ... on behalf of a class consisting of all persons ... 2014 and May 13, 2015 inclusive (the "Class Period").  ...
(Date:7/2/2015)... ... 03, 2015 , ... Cuvettes have been used in countless labs for decades. In the ... they needed. As expected, this was a daunting and tiring process looking at endless ... were not able to navigate the complex catalog structure. , Now thanks to FireflySci, scientists ...
(Date:7/2/2015)... , July 2, 2015  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, today announced a ... Spherix Incorporated v. Verizon Services Corp. et al. , ... for the Eastern District of Virginia ... 1, 2015 interpreting certain key claims in favor of ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4New Cuvette E-Commerce Website Launched by FireflySci 2Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3
... , , SOUTH SAN FRANCISCO, ... today announced that 320 evaluable events (patient deaths) have occurred in its ... is being conducted in accordance with a Special Protocol Assessment (SPA) with ... of small cell lung cancer (SCLC). , , ...
... WOBURN, Mass., Sept. 15 BioVex Inc, a biotechnology ... infectious disease, announced today that the U.S. Food and Drug Administration ... clinical trial evaluating its lead product, OncoVEX (GM-CSF), for the first-line ... neck. , , The study is the ...
... , SAN DIEGO, Sept. 15 ... with China, today announced a strategic partnership agreement with Guangzhou ... HUYA has established a series of strategic partnerships with Chinese ... portfolio of novel biopharmaceutical products. The agreement with GIBH provides ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 5BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX (GM-CSF) in Head and Neck Cancer 4HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 2HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH) 3
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
WIF-1 (N-20)...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Biology Products: